Samuel Blackman
2020
In 2020, Samuel Blackman earned a total compensation of $477.1K as Co-Founder and Chief Medical Officer at Day One Biopharmaceuticals.
Compensation breakdown
Non-Equity Incentive Plan | $110,100 |
---|---|
Salary | $367,000 |
Total | $477,100 |
Blackman received $367K in salary, accounting for 77% of the total pay in 2020.
Blackman also received $110.1K in non-equity incentive plan.
Rankings
In 2020, Samuel Blackman's compensation ranked 11,155th out of 13,090 executives tracked by ExecPay. In other words, Blackman earned more than 14.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,155 out of 13,090 | 15th |
Division Manufacturing | 4,772 out of 5,624 | 15th |
Major group Chemicals And Allied Products | 1,983 out of 2,257 | 12th |
Industry group Drugs | 1,734 out of 1,957 | 11th |
Industry Pharmaceutical Preparations | 1,281 out of 1,462 | 12th |
Source: SEC filing on April 28, 2022.
Blackman's colleagues
We found one more compensation record of an executive who worked with Samuel Blackman at Day One Biopharmaceuticals in 2020.
2020
Jeremy Bender
Day One Biopharmaceuticals